MedPath

Etoricoxib

Generic Name
Etoricoxib
Drug Type
Small Molecule
Chemical Formula
C18H15ClN2O2S
CAS Number
202409-33-4
Unique Ingredient Identifier
WRX4NFY03R

Overview

Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.

Indication

For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.

Associated Conditions

  • Ankylosing Spondylitis (AS)
  • Gout
  • Osteoarthritis (OA)
  • Rheumatoid Arthritis
  • Moderate Pain

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/03/25
Phase 3
Recruiting
2025/03/07
Phase 3
Recruiting
2024/07/24
Phase 3
Completed
2024/05/06
Phase 4
Not yet recruiting
Muhammad Ilyas
2023/08/21
Not Applicable
Completed
Guangdong Provincial Hospital of Traditional Chinese Medicine
2023/03/30
Phase 4
Completed
2023/01/13
Phase 3
Withdrawn
Eurofarma Laboratorios S.A.
2022/09/08
Phase 1
Completed
2022/09/08
Phase 1
Completed
2022/02/25
Not Applicable
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Etoricoxib Tablets
国药准字H20193302
化学药品
片剂
11/4/2019
Etoricoxib Tablets
国药准字H20213897
化学药品
片剂
11/24/2021
Etoricoxib Tablets
国药准字H20254037
化学药品
片剂
4/30/2025
Etoricoxib Tablets
国药准字H20254038
化学药品
片剂
4/30/2025
Etoricoxib Tablets
国药准字H20253148
化学药品
片剂
1/14/2025
Etoricoxib Tablets
国药准字H20253147
化学药品
片剂
1/14/2025
Etoricoxib Tablets
国药准字H20193303
化学药品
片剂
11/4/2019
Etoricoxib Tablets
国药准字H20234007
化学药品
片剂
8/1/2023
Etoricoxib Tablets
国药准字H20253146
化学药品
片剂
1/14/2025
Etoricoxib Tablets
国药准字HJ20230114
化学药品
片剂
10/18/2023

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
APTOXIA TABLETS 120MG
N/A
synco (h.k.) limited
N/A
N/A
9/24/2018

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath